STOCK TITAN
  1. Home
  2. Sec-filings
  3. INVX
  4. [Form 4] Innovex International, Inc. Insider Trading Activity

Innovex International (INVX) funds sell 5M shares at $28.71 in secondary

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Innovex International, Inc. insiders affiliated with Amberjack Capital Partners and Innovex Co-Invest reported net sales of 5,000,000 shares of common stock on 2026-08-10. The shares were sold indirectly by several investment funds in an underwritten secondary offering at $28.71 per share to Barclays Capital Inc., pursuant to a Rule 10b5-1 trading plan. After these sales, Amberjack Capital Fund II, L.P. reported holding 13,164,573 shares, with other affiliated funds retaining smaller positions, and Jason Turowsky disclaimed beneficial ownership beyond his pecuniary interests.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Amberjack Capital Partners, L.P., Amberjack Capital Associates II, LLC, Amberjack Capital Fund II, L.P., Amberjack Capital GP II, L.P., Innovex Co-Invest Associates, LLC, Innovex Co-Invest Fund II GP, L.P., Innovex Co-Invest Fund II, L.P., Turowsky Jason, Amberjack Management, LLC
Role Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner
Sold 5,000,000 shs ($143.55M)
Type Security Shares Price Value
Sale Common Stock F1, F7, F8, F9, F10 3,706,801 $28.71 $106.42M
Sale Common Stock F2, F7, F8, F9, F10 865,508 $28.71 $24.85M
Sale Common Stock F3, F7, F8, F9, F10 205,126 $28.71 $5.89M
Sale Common Stock F4, F7, F8, F9, F10 176,944 $28.71 $5.08M
Sale Common Stock F5, F7, F8, F9, F10 88 $28.71 $3K
Sale Common Stock F6, F7, F8, F9, F10 45,533 $28.71 $1.31M
Holdings After Transaction: Common Stock — 13,164,573 shares (Indirect, By Amberjack Capital Fund II, L.P.); Common Stock — 3,073,822 shares (Indirect, By Innovex Co-Invest Fund II, L.P.); Common Stock — 728,498 shares (Indirect, By Innovex Co-Invest Fund, L.P.); Common Stock — 628,411 shares (Indirect, By Intervale Capital Fund II, L.P.); Common Stock — 311 shares (Indirect, By Intervale Capital Fund II-A, L.P.); Common Stock — 161,707 shares (Indirect, By Intervale Capital Fund III, L.P.)
Footnotes (10)
  1. F1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to Barclays Capital Inc. (the "Underwriter") of $28.71 per share.
  2. F2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  3. F3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  4. F4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  5. F5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  6. F6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  7. F7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
  8. F8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
  9. F9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
  10. F10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Total shares sold 5,000,000 shares Aggregate common stock sold by affiliated funds on 2026-08-10
Sale price per share $28.71 Price to Barclays Capital Inc. as underwriter in the Offering
Amberjack Capital Fund II post-sale holdings 13,164,573 shares Indirect holdings after its reported sale of common stock
Innovex Co-Invest Fund II post-sale holdings 3,073,822 shares Indirect holdings after its reported sale of common stock
Innovex Co-Invest Fund post-sale holdings 728,498 shares Indirect holdings after its reported sale of common stock
Intervale Capital Fund II post-sale holdings 628,411 shares Indirect holdings after its reported sale of common stock
Intervale Capital Fund II-A post-sale holdings 311 shares Indirect holdings after its reported sale of common stock
Intervale Capital Fund III post-sale holdings 161,707 shares Indirect holdings after its reported sale of common stock
underwritten secondary offering financial
"shares of common stock ... were sold in an underwritten secondary offering (the "Offering")"
An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.
beneficial owner financial
"therefore may be deemed to be the beneficial owner of such shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
voting and dispositive power financial
"control all voting and dispositive power over the reported shares held"
pecuniary interests financial
"Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider stock sales did Innovex International (INVX) report on August 10, 2026?
Innovex International (INVX) reported that affiliated funds sold 5,000,000 shares of common stock on 2026-08-10. The shares were sold indirectly by multiple Amberjack and Innovex Co-Invest funds in an underwritten secondary offering at $28.71 per share to Barclays Capital Inc.

At what price were Innovex International (INVX) shares sold in the reported insider transactions?
The shares were sold at $28.71 per share to Barclays Capital Inc. as underwriter. Each participating fund’s sale in the underwritten secondary offering used this same price, according to the footnotes describing the Offering and the role of the Underwriter.

How many Innovex International (INVX) shares does Amberjack Capital Fund II, L.P. hold after the sale?
After the reported sale, Amberjack Capital Fund II, L.P. held 13,164,573 shares of Innovex common stock indirectly. These shares remain subject to voting and dispositive control relationships described among Amberjack general partners and management entities in the footnotes.

Which entities sold Innovex International (INVX) shares in the underwritten secondary offering?
Selling entities included Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund II, L.P., Innovex Co-Invest Fund, L.P., Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., and Intervale Capital Fund III, L.P. Each sold common stock as part of the same underwritten secondary offering.

Was the Innovex International (INVX) insider selling done under a Rule 10b5-1 trading plan?
Yes. The filing indicates the transactions were effected under a Rule 10b5-1 trading plan. This means the sales followed a pre-established trading arrangement, which can reduce the informational significance of the timing of the transactions for outside investors.

What does Jason Turowsky disclose about his beneficial ownership of Innovex (INVX) shares?
Jason Turowsky is managing partner of Amberjack Management but disclaims beneficial ownership of securities beyond his pecuniary interests. The footnotes explain that voting and dispositive power resides in affiliated Amberjack entities, which may be deemed beneficial owners of the reported shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Amberjack Capital Partners, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026S3,706,801D$28.71(1)(7)(8)(9)(10)13,164,573IBy Amberjack Capital Fund II, L.P.
Common Stock08/10/2026S865,508D$28.71(2)(7)(8)(9)(10)3,073,822IBy Innovex Co-Invest Fund II, L.P.
Common Stock08/10/2026S205,126D$28.71(3)(7)(8)(9)(10)728,498IBy Innovex Co-Invest Fund, L.P.
Common Stock08/10/2026S176,944D$28.71(4)(7)(8)(9)(10)628,411IBy Intervale Capital Fund II, L.P.
Common Stock08/10/2026S88D$28.71(5)(7)(8)(9)(10)311IBy Intervale Capital Fund II-A, L.P.
Common Stock08/10/2026S45,533D$28.71(6)(7)(8)(9)(10)161,707IBy Intervale Capital Fund III, L.P.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Amberjack Capital Partners, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Amberjack Capital Associates II, LLC
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUNSTON TEXAS 77207
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Amberjack Capital Fund II, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Amberjack Capital GP II, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Innovex Co-Invest Associates, LLC
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Innovex Co-Invest Fund II GP, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Innovex Co-Invest Fund II, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Turowsky Jason
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Amberjack Management, LLC
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITR 2760
(Street)
HOUOSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to Barclays Capital Inc. (the "Underwriter") of $28.71 per share.
2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Remarks:
This Form 4 is the first of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The second of two Forms 4 was filed by the designated filer Innovex Co-Invest Fund, L.P.
AMBERJACK CAPITAL PARTNERS, L.P., By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Managing Partner08/10/2026
AMBERJACK CAPITAL FUND II, L.P., By: Amberjack Capital GP II, L.P., its general partner, By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
AMBERJACK CAPITAL GP II, L.P., By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
AMBERJACK CAPITAL ASSOCIATES II, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
AMBERJACK MANAGEMENT, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
JASON TUROWSKY, /s/ Jason Turowsky08/10/2026
INNOVEX CO-INVEST FUND II, L.P., By: Innovex Co-Invest Fund II GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INNOVEX CO-INVEST FUND II GP, L.P., By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INNOVEX CO-INVEST ASSOCIATES, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR